[1] LEZAIC N, ROUSSY J, MASSON H, et al. Epilepsy in the elderly: Unique challenges in an increasingly prevalent population[J]. Epilepsy Behav, 2020, 102:106724.
[2] CVETKOVSKA E, BABUNOVSKA M, BOSKOVSKI B, et al. Prevalence of various risk factors associated with new-onset epilepsy after the age of 50: a retrospective population-based study[J]. Epileptic Disord, 2022, 24(1):95-101.
[3] GRAHAM N S, CRICHTON S, KOUTROUMANIDIS M, et al. Incidence and associations of poststroke epilepsy: the prospective south London stroke register[J]. Stroke, 2013, 44(3):605-611.
[4] FERREIRA-ATUESTA C, DÖHLER N, ERDÉLYI-CANAVESE B, et al. Seizures after ischemic stroke: a matched multicenter study[J]. Ann Neurol, 2021, 90(5):808-820.
[5] ENGLOT D J, CHANG E F, VECHT C J. Epilepsy and brain tumors[J]. Handb Clin Neurol, 2016,134:267-285.
[6] CHEN D Y, CHEN C C, CRAWFORD J R, et al. Tumor-related epilepsy: epidemiology, pathogenesis and management[J]. J Neurooncol, 2018, 139(1):13-21.
[7] DUN, C ZHANG Y, YIN J, et al. Bi-directional associations of epilepsy with dementia and Alzheimer's disease: a systematic review and meta-analysis of longitudinal studies[J]. Age Ageing, 2022, 51(3):afac010.
[8] STEFANIDOU M, BEISER A S, HIMALI J J, et al. Bi-directional association between epilepsy and dementia: The Framingham Heart Study[J]. Neurology, 2020, 95(24):e3241-e3247.
[9] LOLK K, DREIER J W, CHRISTENSEN J. Repeated traumatic brain injury and risk of epilepsy: a Danish nationwide cohort study[J]. Brain, 2021, 144(3):875-884.
[10] IZUMI M, OKABE T, KOMURA M, et al. Convulsive syncope on electroencephalogram[J]. J Gen Fam Med, 2018, 19(3):109-110.
[11] LEHN A, WATSON E, RYAN E G, et al. Psychogenic nonepileptic seizures treated as epileptic seizures in the emergency department[J]. Epilepsia, 2021, 62(10):2416-2425.
[12] ZERAH L, BIHAN K, KOHLER S, et al. Iatrogenesis and neurological manifestations in the elderly[J]. Rev Neurol: Paris, 2020, 176(9):710-723.
[13] SULLER MARTI A, BELLOSTA DIAGO E, et al. Epilepsy in elderly patients: does age of onset make a difference?[J]. Neurologia: Engl Ed, 2022, 37(3):171-177.
[14] 郎森阳.老年患者首发抽搐的诊断和处理[J]. 中华保健医学杂志, 2008, 10(1):6-10.
[15] ZHANG Y J, LU X M, LI P W, et al. Oxcarbazepine versus Carbamazepine for the treatment of post-stroke epilepsy: a systematic review and meta-analysis[J]. Turk Neurosurg, 2022, 32(2):176-184.
[16] MO F, MELETTI S, BELCASTRO V, et al. Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study[J]. J Neurooncol, 2022, 157(3):551-559.
[17] MASCOLO A P, MARRAMA F, MERCURI N B, et al. Efficacy and safety of lacosamide in the treatment of status epilepticus in a patient with comorbidities[J]. Acta Biomed, 2021, 92(S1):e2021090.
[18] GURBANI S, CHAYASIRISOBHON S, GURBANI A, et al. Effectiveness at 24 months of single-source generic Carbamazepine, Lamotrigine, or Levetiracetam in newly diagnosed focal epilepsy[J]. Perm J, 2020, 25:1-3.
[19] LI R, ZHOU Q, OU S, et al. Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: an observational study in the real world[J]. Epilepsy Res, 2020, 166:106408.
[20] SAETRE E, PERUCCA E, ISOJÄRVI J, et al. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release Carbamazepine in the treatment of newly diagnosed epilepsy in the elderly[J]. Epilepsia, 2007, 48(7):1292-1302.
[21] HE J, WU X, ZHOU D. The efficacy of lamotrigine after failure of the first administration of valproate in treating epilepsy: a systematic review and meta-analysis[J]. Ann Palliat Med, 2022, 11(1):113-122.
[22] LARSSON D, BAFTIU A, JOHANNESSEN LANDMARK C, et al. Association between antiseizure drug monotherapy and mortality for patients with poststroke epilepsy[J]. JAMA Neurol, 2022, 79(2):169-175.
[23] RAJNA P, SZÍJÁRTÓ E. Efficacy, safety and effect on the quality of life of gabapentin in adult epilepsy-results of a prospective open-label quasi naturalistic hungarian multicenter study (phase human-IV) [J]. Ideggyogy Sz, 2006, 59(9/10):361-372.
[24] 朱国行, 丁美萍, 肖波, 等.加巴喷丁对难治性癫痫的治疗作用[J]. 中华医学杂志, 2005, 85(2):92-95.
[25] HARITSA S V, REDDY K J, RAFIQ A, et al.Randomized trials of psychotherapeutic treatment for psychogenic seizures: scoping review[J]. Indian J Psychol Med, 2021, 43(6):469-472. |
